Survey Report: Biosimilars in Alberta and BC

Survey Report: Biosimilars in Alberta and BC Four provinces across Canada have implemented non-medical switching (NMS) policies for biologic medications. In these jurisdictions, to maintain public coverage, individuals must switch from their originator biologic to a corresponding biosimilar. In May [...]

2021-11-11T10:15:24-08:00December 20, 2021|

Biosimilars Patient Survey – AB and BC

Biosimilars Survey 2021 The Gastrointestinal Society represents Canadian patients on a variety of healthcare fronts, including access to medications. We have designed this survey to help us understand your opinions and outlook regarding switching from originator biologics to their biosimilars. [...]

2021-08-31T15:05:16-07:00August 31, 2021|

More PMPRB Revisions During Legal Challenges, COVID-19, and an Election

More PMPRB Revisions During Legal Challenges, COVID-19, and an Election As you may know, the Patented Medicine Prices Review Board (PMPRB), is a quasi-judicial federal agency that calculates the maximum prices of patented medicines. There have been several developments in [...]

2021-08-31T13:32:07-07:00August 31, 2021|
Go to Top